# ACUVUE THERAVISION WITH KETOTIFEN
> **NDA022388** · New Drug Application · Sponsor: JOHNSON JOHNSON VISN · Approved 2022-02-25
## Drug
- **FDA Application Number:** NDA022388
- **Application type:** New Drug Application
- **Brand name:** ACUVUE THERAVISION WITH KETOTIFEN
- **Generic name:** Ketotifen Fumarate
- **Active ingredients:** KETOTIFEN FUMARATE
- **Dosage form:** DRUG-ELUTING CONTACT LENS
- **Route:** OPHTHALMIC
- **Marketing status:** Discontinued
- **Sponsor:** JOHNSON JOHNSON VISN
- **First approval:** 2022-02-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022388)
---
*MORVS · CC0 1.0*